M2VA Pain Care Pathway for Pain
(M2VAPCP Trial)
Trial Summary
What is the purpose of this trial?
The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention. The main questions it aims to answer are: Will adding implementation facilitation to training-as-usual for M2VAPCP result in a higher proportion of Veterans who receive M2VAPCP compared to training-as-usual alone? Will adding implementation facilitation to training-as-usual for M2VAPCP result in better adherence to the M2VAPCP protocol compared to training-as-usual alone? Will implementation facilitation improve Veterans' clinical outcomes (pain, risky substance use) and increase the number of non-pharmacological pain treatments used compared to training-as-usual alone?
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the M2VA Pain Care Pathway treatment?
Research shows that clinical pathways, like the M2VA Pain Care Pathway, can improve patient care by integrating evidence-based practices and enhancing teamwork among healthcare providers. These pathways have been effective in other settings, such as hospitals and community teams, by standardizing care and improving outcomes.12345
Is the M2VA Pain Care Pathway generally safe for humans?
How is the M2VA Pain Care Pathway treatment different from other pain management treatments?
The M2VA Pain Care Pathway is unique because it uses an implementation facilitation strategy, which involves interactive problem-solving and support to help healthcare providers implement a collaborative care program for pain management. This approach focuses on reducing high-dose opioid use and promoting safer, multi-modal pain care models, which is different from traditional pain management methods that may not emphasize provider support and collaborative care.911121314
Research Team
Marc Rosen, MD
Principal Investigator
Yale University
Eligibility Criteria
This trial is for veterans dealing with pain and at risk of or currently facing substance use issues, specifically opioid abuse. It's designed to help case managers better adopt a special care pathway to improve these veterans' quality of life.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
M2VA case managers receive an initial 8-hour virtual didactic and experiential workshop on Motivational Interviewing and M2VAPCP protocol
Implementation Facilitation
Implementation facilitation strategy to support the use of M2VAPCP, including external facilitation team and multifaceted activities
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on pain and substance use outcomes
Treatment Details
Interventions
- Implementation Facilitation
- M2VA Pain Care Pathway (M2VAPCP)
Implementation Facilitation is already approved in United States for the following indications:
- Improving pain care pathways
- Enhancing non-pharmacological pain treatments
- Reducing risky substance use
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
VA Connecticut Healthcare System
Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Collaborator